NCT07211269 Individual Differences in Cognitive Control Predict Real-time fMRI Neurofeedback Performance
| NCT ID | NCT07211269 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Electronic Science and Technology of China |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-09-03 |
| Primary Completion | 2025-12-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-09-03 with a primary completion date of 2025-12-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to investgate whether individual differences of cognitive control capacity could predict neurofeedback performance and the behavioral effects resulting from successful anterior insula regulation via interoceptive strategy.
Eligibility Criteria
Inclusion Criteria: * Healthy subjects without any past or present psychiatric or neurological disorders Exclusion Criteria: * History of brain injury Medical or mental illness and color blindness or weakness. * The presence of metal in the body or claustrophobia.
Contact & Investigator
Yao Shuxia, Dr.
PRINCIPAL INVESTIGATOR
University of Electronic Science and Technology of China
Frequently Asked Questions
Who can join the NCT07211269 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07211269 currently recruiting?
Yes, NCT07211269 is actively recruiting participants. Contact the research team at k.kendrick.uestc@gmail.com for enrollment information.
Where is the NCT07211269 trial being conducted?
This trial is being conducted at Chengdu, China.
Who is sponsoring the NCT07211269 clinical trial?
NCT07211269 is sponsored by University of Electronic Science and Technology of China. The principal investigator is Yao Shuxia, Dr. at University of Electronic Science and Technology of China. The trial plans to enroll 40 participants.